Artificial Intelligence in Laryngeal Cancer Management: Enhancing Guidelines or Redefining Standards?

article
Autores

Dedivitis, Rogério Aparecido

De Castro, Mario Augusto Ferrari

Matos, Leandro Luongo

Ribeiro, Daniel Araki

Duarte, Bruno Pelison

Kowalski, Luiz Paulo

Data de Publicação

1 de dezembro de 2025

Resumo

ABSTRACT Objective To evaluate the accuracy of artificial intelligence (AI) in establishing clinical decision‐making in the treatment of advanced laryngeal cancer. Methods A structured question was elaborated for each of the seven recommendations chosen. Each Large Language Model (LLM) platform answered the questions. The Claude platform identified the differences between the guidelines and the responses generated and three specialists evaluated the impact of such differences. Results Of the 28 analyzed responses, 22 (78.6%) demonstrated content similarity with existing guidelines. Two responses showed that guidelines contained significantly more comprehensive content, three responses from LLMs provided additional content not demonstrated in the guidelines, and one response showed direct disagreement with established guidelines. Conclusion There was a 78.6% overlap in responses between guideline recommendations and LLMs. Therefore, while AI holds promise for transforming guideline creation, its integration into clinical practice must be carefully evaluated to ensure that it complements, rather than replaces, established expert‐driven protocols. Level of Evidence 4.

Citação

BibTeX
@online{rogério_aparecido2025,
  author = {Rogério Aparecido , Dedivitis and Castro, Mario Augusto
    Ferrari, De and Leandro Luongo , Matos and Daniel Araki , Ribeiro
    and Bruno Pelison , Duarte and Luiz Paulo , Kowalski},
  title = {Artificial Intelligence in Laryngeal Cancer Management:
    Enhancing Guidelines or Redefining Standards?},
  volume = {10},
  number = {6},
  date = {2025-12-01},
  doi = {10.1002/lio2.70296},
  langid = {pt-BR},
  abstract = {ABSTRACT Objective To evaluate the accuracy of artificial
    intelligence (AI) in establishing clinical decision‐making in the
    treatment of advanced laryngeal cancer. Methods A structured
    question was elaborated for each of the seven recommendations
    chosen. Each Large Language Model (LLM) platform answered the
    questions. The Claude platform identified the differences between
    the guidelines and the responses generated and three specialists
    evaluated the impact of such differences. Results Of the 28 analyzed
    responses, 22 (78.6\%) demonstrated content similarity with existing
    guidelines. Two responses showed that guidelines contained
    significantly more comprehensive content, three responses from LLMs
    provided additional content not demonstrated in the guidelines, and
    one response showed direct disagreement with established guidelines.
    Conclusion There was a 78.6\% overlap in responses between guideline
    recommendations and LLMs. Therefore, while AI holds promise for
    transforming guideline creation, its integration into clinical
    practice must be carefully evaluated to ensure that it complements,
    rather than replaces, established expert‐driven protocols. Level of
    Evidence 4.}
}
Por favor, cite este trabalho como:
Rogério Aparecido, Dedivitis, De Castro, Mario Augusto Ferrari, Matos Leandro Luongo, Ribeiro Daniel Araki, Duarte Bruno Pelison, and Kowalski Luiz Paulo. 2025. “Artificial Intelligence in Laryngeal Cancer Management: Enhancing Guidelines or Redefining Standards?” Laryngoscope Investigative Otolaryngology. December 1, 2025. https://doi.org/10.1002/lio2.70296.